Category Archives: Oncology

Update on cases of lymphoma linked to textured breast implants in transgender women (BIA-ALCL)

I’ve previously covered emerging findings on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma caused by the textured surfaces of some implants used in breast augmentation surgeries. Textured surfaces have been used in some breast implants to … Continue reading

Posted in Health care, Oncology, Surgery, Transfeminine | Tagged , | Leave a comment

Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Disclaimer: I am not a medical professional and this is not medical advice. Cyproterone acetate (CPA) … Continue reading

Posted in Endocrinology, Oncology, Transfeminine, Transgender medicine | Tagged , , , | 1 Comment

Trans women and transfeminine people taking HRT are far less likely to develop prostate cancer

Concerns over supposedly cancer-causing effects of cross-sex hormone therapy are an area in which public alarm has often pulled far ahead of the facts on transition and transgender health. For instance, in 2019, the Telegraph breathlessly reported that the “risk … Continue reading

Posted in Endocrinology, Media, Oncology, Transphobia and prejudice | Tagged , , , , | Leave a comment

Further publications on BRCA1/2 variants and their impact on transitioning

Disclaimer: I am not a doctor and this is not medical advice. Last year, I wrote about case studies of pathological BRCA1 and BRCA2 gene variants in trans people, and how clinicians take these mutations into account during transition treatment. … Continue reading

Posted in Endocrinology, Oncology, Surgery, Transgender medicine | Tagged , | Leave a comment

Update on case reports: Cyproterone acetate and meningioma in trans women

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Disclaimer: I am not a doctor, and this is not medical advice. Do not take any medication without appropriate medical supervision. Summary Cyproterone acetate (CPA) is commonly used as … Continue reading

Posted in Endocrinology, Oncology, Transgender medicine | Tagged , , | Leave a comment